The <scp>AhR‐SRC</scp> axis as a therapeutic vulnerability in <scp>BRAFi</scp> ‐resistant melanoma-Reference-Cited by-同舟云学术

The AhR‐SRC axis as a therapeutic vulnerability in BRAFi ‐resistant melanoma

Published:2022-10-28 Issue:12 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Paris Anaïs¹^ORCID,Tardif Nina¹^ORCID,Baietti Francesca M²³^ORCID,Berra Cyrille¹⁴^ORCID,Leclair Héloïse M¹^ORCID,Leucci Eleonora²³^ORCID,Galibert Marie‐Dominique¹⁴^ORCID,Corre Sébastien¹^ORCID

Affiliation:

1. Univ Rennes, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes) – UMR6290, ERL U1305 Rennes France

2. Laboratory for RNA Cancer Biology, Department of Oncology LKI, KU Leuven Leuven Belgium

3. Trace PDX Platform, Department of Oncology LKI, KU Leuven Leuven Belgium

4. Department of Molecular Genetics and Genomics Hospital University of Rennes (CHU Rennes) Rennes France

Funder

College of Natural Resources and Sciences, Humboldt State University

Institut National de la Santé et de la Recherche Médicale

CNIB

Ligue Contre le Cancer

Stichting Tegen Kanker

Université de Rennes 1

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202215677

Reference84 articles.

1. OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs

2. Overcoming resistance to BRAF inhibitors

3. Comprehensive Characterization of Cancer Driver Genes and Mutations

4. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

5. The emerging clinical relevance of genomics in cancer medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dendritic cell-recruiting, antimicrobial blood clot hydrogel for melanoma recurrence prevention and infected wound management;Biomaterials;2025-02

2. The Aryl Hydrocarbon Receptor Controls IFNγ-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung Adenocarcinoma;2024-08-13

3. Loss of LYN Is Frequent in Targeted Therapy–Resistant Melanoma Cells and Favors Metastatic Properties;Journal of Investigative Dermatology;2024-07

4. Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling;Cancers;2024-06-18

5. SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma;Oncogene;2023-12-15